K. Annis

Association of medically treated depression and age at natural menopause.

D. Cramer, B. Harlow, K. Annis, 1995, American journal of epidemiology.

Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor.

K. Cooper, C. Sigler, K. Annis, 1997, Archives of dermatology.

Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.

J. Rouleau, A. Ducharme, B. Chaitman, 2003, Journal of the American College of Cardiology.

Whole‐Patient Measure of Safety: Using Administrative Data to Assess the Probability of Highly Undesirable Events During Hospitalization

S. Hohmann, R. Perla, K. Annis, 2013, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

LEAP: Lead, Excel, Achieve, Perform

Colleen H. Swartz, S. Hohmann, T. Sundt, 2012 .

Efficacy and Safety of Intravenous Tanezumab for the Symptomatic Treatment of Osteoarthritis: 2 Randomized Controlled Trials versus Naproxen

E. Ekman, J. Gimbel, Mark T. Brown, 2014, The Journal of Rheumatology.